The role of PPARγ in the progression of esophageal cancer remains controversial: activation of PPARγ inhibits cell growth and induces apoptosis in vitro; however, PPARγ agonists promote tumor growth in xenografted mice. Here, PPARG is linked to esophageal cancer.